Concept Map on Toxic Stress in Newborns

May 16, 2024 updated by: Aylin PEKYİGİT, Çankırı Karatekin University

Effect of Concept Map on Nursing Students' Ability to Assess Toxic Stress in Newborns: A Randomized Controlled Trial

This study will be conducted as a single-blind randomized control group intervention trial to examine the effect of using concept maps on the students' knowledge levels about toxic stress in newborns, which is explained to second-year nursing students.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The Newborn Toxic Stress Knowledge Test (1st Test) will be administered to intervention and control group students who agree to participate in the research, before the 4-hour High Risk Newborn theoretical lecture. Training on Toxic Stress in Newborns will be given to both groups, and then a post-training knowledge test (2nd Test) will be administered. The initiative group will be composed of students who apply concept maps and make in-class maintenance plans after theoretical training. The control group will consist of students who receive theoretical training and implement in-class care plans. After the concept map application, a knowledge test will be applied again (3rd Test).

The data of the research will be collected with the Personal Information Form and Newborn Toxic Stress Information Test.

The personal information form was prepared by the researchers. In shape; There are questions about the student's age, gender, secondary school graduation status, whether they choose the nursing profession willingly, whether they consider the nursing profession suitable for themselves, whether they have heard the term concept map and whether they have applied concept map.

Newborn Toxic Stress Information Test was prepared by researchers. The test consists of 25 multiple choice questions. It consists of true, false and I don't know options.

Study Type

Interventional

Enrollment (Estimated)

110

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Enrolled in the course
  • Had not taken this course before
  • Accepted to participate in the research

Exclusion Criteria:

  • Have any records of absence
  • Taken this course before
  • Graduate of health vocational high school

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Concept Map Group
The intervention group will create a concept map regarding neonatal toxic stress.
Other: Concept map group
The intervention group will create a concept map regarding neonatal toxic stress.
No Intervention: Control Group
During the application process of the research, knowledge tests will be applied as pre-test and post-test

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Differences of knowledge scores between groups
Time Frame: The first knowledge test (pre-test) will be given before class in the first week. Two knowledge tests will be administered for the final test. Total duration is 4 weeks.
First, second and thirth knowledge tests will be applied to measure the level of knowledge. The student can get a minimum of 0 and a maximum of 100 from the knowledge test. Higher scores mean better results.
The first knowledge test (pre-test) will be given before class in the first week. Two knowledge tests will be administered for the final test. Total duration is 4 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Çankırı Karatekin University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 6, 2024

Primary Completion (Estimated)

May 13, 2024

Study Completion (Estimated)

June 6, 2024

Study Registration Dates

First Submitted

April 24, 2024

First Submitted That Met QC Criteria

May 16, 2024

First Posted (Actual)

May 17, 2024

Study Record Updates

Last Update Posted (Actual)

May 17, 2024

Last Update Submitted That Met QC Criteria

May 16, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • CKU12

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nursing Education

Clinical Trials on Concept map group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe